Advanced Pharmacotherapeutics VI

• • Psychiatric disorders
  • Neurological disorders
  • Psychiatric and neurological medication therapy
  • Clinical auditing for disease management
  • Contemporary issues in medication therapy

You must either have successfully completed the following subject(s) before starting this subject, or currently be enrolled in the following subject(s) in a prior study period; or enrol in the following subject(s) to study prior to this subject:

• TAS-CSA721-Advanced Pharmacotherapeutics I

Please note that your enrolment in this subject is conditional on successful completion of these prerequisite subject(s). If you study the prerequisite subject(s) in the study period immediately prior to studying this subject, your result for the prerequisite subject(s) will not be finalised prior to the close of enrolment. In this situation, should you not complete your prerequisite subject(s) successfully you should not continue with your enrolment in this subject. If you are currently enrolled in the prerequisite subject(s) and believe you may not complete these all successfully, it is your responsibility to reschedule your study of this subject to give you time to re-attempt the prerequisite subject(s)

Additional requirements

No additional requirements

CSA726 is a self-directed, fully on-line subject, that explores a variety of disease states and their management, using a series of patient cases linked to assignment based questions, to enable the student to enhance their knowledge in the area of clinical pharmacy and pharmaceutical care.

• Multiple Choice Quiz (5%)
• Clinical Case Reflection (35%)
• Poster Presentation (20%)
• Case Study Summaries (15%%)
• Case Study Test (25%)

Current study term: 11 Jul 21 to 17 Oct 21